Toronto Dominion Bank
LMNL

Toronto Dominion Bank’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Toronto Dominion Bank’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed – – 1769
2022
Q2 		$0 Hold
2
– – ﹤0.01% 2031
2022
Q1 		$0 Hold
2
– – ﹤0.01% 2154
2021
Q4 		$0 Hold
2
– – ﹤0.01% 2135
2021
Q3 		$0 Sell
2
-21
-91% -$605 ﹤0.01% 1514
2021
Q2 		$4K Hold
23
– – ﹤0.01% 1284
2021
Q1 		$4K Hold
23
– – ﹤0.01% 1342
2020
Q4 		$4K Hold
23
– – ﹤0.01% 1256
2020
Q3 		$4K Buy
23
+10
+77% +$1.35K ﹤0.01% 1128
2020
Q2 		$1K Buy
13
+10
+333% +$884 ﹤0.01% 1219
2020
Q1 		$0 Sell
3
-2
-40% -$180 ﹤0.01% 1507
2019
Q4 		$0 Buy
+5
New +$337 ﹤0.01% 1594

Other funds holding LMNL

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Toronto Dominion Bank's LMNL Position: Q3 2022 in Review

Toronto Dominion Bank sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q3 2022, closing a stake of 2 shares.

Toronto Dominion Bank first reported a position in LMNL in Q4 2019 and held it in 11 quarters. The position peaked at $4K in Q2 2021. 15 funds tracked by Wall St. Rank hold LMNL as of Q3 2022.

  • Toronto Dominion Bank reported no remaining Liminal BioSciences Inc. Common Shares position as of Q3 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 2 Liminal BioSciences Inc. Common Shares shares in Q3 2022.
  • Toronto Dominion Bank first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2019 and held it in 11 quarters.
  • Toronto Dominion Bank's Liminal BioSciences Inc. Common Shares position peaked at $4K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q3 2022.

Based on Toronto Dominion Bank's 13F filing for Q3 2022, filed 9 Nov 2022.